Hybrid high-dose bolus/continuous infusion interleukin-2 in patients with metastatic melanoma: a phase II trial of the Cancer Biotherapy Research Group (formerly the National Biotherapy Study Group).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples